|
1
|
Zhou X, Xin Q, Wang Y, Zhao Y, Chai H,
Huang X, Tao X and Zhao M: Total flavonoids of astragalus plays a
cardioprotective role in viral myocarditis. Acta Cardiol Sin.
32:81–88. 2016.PubMed/NCBI
|
|
2
|
Yu Y, Yu Y, Liu M, Yu P, Liu G, Liu Y, Su
Y, Jiang H and Chen R: Ethyl pyruvate attenuated coxsackievirus
B3-induced acute viral myocarditis by suppression of
HMGB1/RAGE/NF-KB pathway. Springerplus. 5:2152016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rose NR: Viral myocarditis. Curr Opin
Rheumatol. 28:383–389. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun XH, Fu J and Sun DQ: Halofuginone
alleviates acute viral myocarditis in suckling BALB/c mice by
inhibiting TGF-β1. Biochem Biophys Res Commun. 473:558–564. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huber SA: Viral myocarditis and dilated
cardiomyopathy: Etiology and pathogenesis. Curr Pharm Des.
22:408–426. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Werner L, Deutsch V, Barshack I, Miller H,
Keren G and George J: Transfer of endothelial progenitor cells
improves myocardial performance in rats with dilated cardiomyopathy
induced following experimental myocarditis. J Mol Cell Cardiol.
39:691–697. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wen C, Xie G, Zeng P, Huang LF and Chen
CY: Tranilast inhibits myocardial fibrosis in mice with viral
myocarditis. Zhongguo Dang Dai Er Ke Za Zhi. 18:446–454. 2016.(In
Chinese). PubMed/NCBI
|
|
8
|
Li-Sha G, Jing-Lin Z, Guang-Yi C, Li L,
De-Pu Z and Yue-Chun L: Erratum: Dose-dependent protective effect
of nicotine in a murine model of viral myocarditis induced by
coxsackievirus B3. Sci Rep. 5:172472015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu H, Lou C and Liu P: Interleukin-27
ameliorates coxsackievirus-B3-induced viral myocarditis by
inhibiting Th17 cells. Virol J. 12:1892015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu MX, Yu R, Shao LF, Zhang YX, Ge CX, Liu
XM, Wu WY, Li JM and Kong LD: Up-regulated fractalkine (FKN) and
its receptor CX3CR1 are involved in fructose-induced
neuroinflammation: Suppression by curcumin. Brain Behav Immun.
58:69–81. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Poniatowski ŁA, Wojdasiewicz P, Krawczyk
M, Szukiewicz D, Gasik R, Kubaszewski Ł and Kurkowska-Jastrzębska
I: Analysis of the role of CX3CL1 (Fractalkine) and its receptor
CX3CR1 in traumatic brain and spinal cord injury: Insight into
recent advances in actions of neurochemokine agents. Mol Neurobiol.
54:2167–2188. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Julia V, Staumont-Salle D and Dombrowicz
D: Role of fractalkine/CX3CL1 and its receptor CX3CR1 in allergic
diseases. Med Sci (Paris). 32:260–266. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bagci B, Bagci G, Huzmeli C, Sezgin I and
Ozdemir O: Associations of fractalkine receptor (CX3CR1) and CCR5
gene variants with hypertension, diabetes and atherosclerosis in
chronic renal failure patients undergoing hemodialysis. Int Urol
Nephrol. 48:1163–1170. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zanier ER, Marchesi F, Ortolano F, Perego
C, Arabian M, Zoerle T, Sammali E, Pischiutta F and De Simoni MG:
Fractalkine receptor deficiency is associated with early protection
but late worsening of outcome following brain trauma in mice. J
Neurotrauma. 33:1060–1072. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim SM, Kim H, Jang KW, Kim MH, Sohn J,
Yun MR, Kang HN, Kang CW, Kim HR, Lim SM, et al: EGFR-mediated
reactivation of MAPK signaling induces acquired resistance to
GSK2118436 in BRAF V600E mutant NSCLC cell lines. Mol Cancer Ther.
15:1627–1636. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chandaka GK, Wang L, Senogles S and
Armstrong WE: Late pregnancy is a critical period for changes in
phosphorylated mitogen-activated protein kinase/extracellular
signal-regulated kinase 1/2 in oxytocin neurons. J Neuroendocrinol.
doi: 10.1111/jne.12398. PubMed/NCBI
|
|
17
|
Itoh S, Ding B, Bains CP, Wang N, Takeishi
Y, Jalili T, King GL, Walsh RA, Yan C and Abe J: Role of p90
ribosomal S6 kinase (p90RSK) in reactive oxygen species and protein
kinase C beta (PKC-beta)-mediated cardiac troponin I
phosphorylation. J Biol Chem. 280:24135–24142. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roux PP, Richards SA and Blenis J:
Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates
extracellular signal-regulated kinase docking and RSK activity. Mol
Cell Biol. 23:4796–4804. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Neise D, Sohn D, Stefanski A, Goto H,
Inagaki M, Wesselborg S, Budach W, Stühler K and Jänicke RU: The
p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma
irradiation-induced apoptosis and mediates senescence via RSK- and
p53-independent accumulation of p21WAF1/CIP1. Cell Death Dis.
4:e8592013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dou Zhongxia ZX: Role of NF-kappa B
pathway in viral myocarditis in mice. J Nanchang Univ (Med Sci).
2016.
|
|
21
|
Ju Y, Wang T, Li Y, Xin W, Wang S and Li
J: Coxsackievirus B3 affects endothelial tight junctions: possible
relationship to ZO-1 and F-actin, as well as p38 MAPK activity.
Cell Biol Int. 31:1207–1213. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dai Q, Zhang D, Yu H, Xie W, Xin R, Wang
L, Xu X, He X, Xiong J, Sheng H, et al: Berberine restricts
coxsackievirus B type 3 replication via inhibition of c-Jun
N-Terminal Kinase (JNK) and p38 MAPK Activation in vitro. Med Sci
Monit. 23:1448–1455. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu J, Zhao J, Petrochenko P, Zheng J and
Hewlett I: Sensitive detection of influenza viruses with Europium
nanoparticles on an epoxy silica sol-gel functionalized
polycarbonate-polydimethylsiloxane hybrid microchip. Biosens
Bioelectron. 86:150–155. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cusinato R, Pacenti M, Martello T, Fattori
P, Morroni M and Palù G: Effectiveness of hydrogen peroxide and
electron-beam irradiation treatment for removal and inactivation of
viruses in equine-derived xenografts. J Virol Methods. 232:39–46.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Elmastour F, Jaidane H, Aguech-Oueslati L,
Benkahla MA, Aouni M, Gharbi J, Sane F and Hober D: Immunoglobulin
G-dependent enhancement of the infection with Coxsackievirus B4 in
a murine system. Virulence. 7:527–535. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Merino JJ, Muñetón-Gómez V, Alvárez MI and
Toledano-Díaz A: Effects of CX3CR1 and fractalkine chemokines in
amyloid beta clearance and p-Tau Accumulation in Alzheimer's
disease (AD) rodent models: Is fractalkine a systemic biomarker for
AD? Curr Alzheimer Res. 13:403–412. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rodriguez-Carballo E, Gámez B and Ventura
F: p38 MAPK signaling in osteoblast differentiation. Front Cell Dev
Biol. 4:402016. View Article : Google Scholar : PubMed/NCBI
|
